Alzprotect
Street
About Alzprotect
AlzProtect is a biopharmaceutical company developing drug candidates from discovery to clinical trials for the treatment of neurodegenerative diseases including Alzheimer's disease (AD) and orphan tauopathies such as Progressive Supranuclear Palsy (PSP).
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: Less than $1M
- Total funding: $20.2M
- Funding stage: Early Stage Venture
- Last round: Grant (Jun 2022)
- Website: alzprotect.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Clinical Trials, Medical, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/alzprotect-24088 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.